Evidence for a Positive Correlation Between Serum Cortisol Levels and IL-1beta Production by Peripheral Mononuclear Cells in Anorexia Nervosa
Overview
Authors
Affiliations
A hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been reported in anorexia nervosa (AN), together with some immunological abnormalities, involving citokine - and particularly Tumor Necrosis-Factor-alpha (TNF-alpha) - production by polymorphonuclear cells. The ability of pro-inflammatory cytokines to activate the HPA axis is well known; however, there are no data demonstrating an interdependence between immunological and endocrine response in AN. To investigate the presence of a correlation between immune response and pituitary-adrenal function, plasma ACTH and serum cortisol concentrations were measured in 13 AN patients and in the same number of controls. TNF-alpha and interleukin (IL)-1beta production by ex-vivo unstimulated and LPS-stimulated peripheral mononuclear cells was also assessed. Circulating cortisol concentrations were higher (p<0.01) in AN (156.7 +/- 45.1 microg/l, mean +/- SD) than in controls (105.9 +/- 25.7 microg/l). Unstimulated IL-1beta release in supernatants of mononuclear cell cultures was slightly but not significantly higher in AN than in controls, while TNF-alpha release was similar in the two groups. A positive correlation was found between IL-1beta concentrations in unstimulated culture supranatants and serum cortisol levels in AN (r=0.782, p=0.002), while in normal subjects there was a trend toward a negative correlation; a slight positive correlation, while not significant, between IL-1beta and plasma ACTH, as well as between TNF-alpha and serum cortisol was also found in AN. These data suggest that the normal relationship between pro-inflammatory cytokines release, particularly IL-1beta, and cortisol secretion is deranged in AN.
Calcaterra V, Magenes V, Fratangeli N, Nigro G, Fabiano V, Mendolicchio L Front Pediatr. 2024; 12:1415061.
PMID: 39726537 PMC: 11669515. DOI: 10.3389/fped.2024.1415061.
Genetic risk factors for eating disorders: an update and insights into pathophysiology.
Himmerich H, Bentley J, Kan C, Treasure J Ther Adv Psychopharmacol. 2019; 9:2045125318814734.
PMID: 30800283 PMC: 6378634. DOI: 10.1177/2045125318814734.
The increased risk for autoimmune diseases in patients with eating disorders.
Raevuori A, Haukka J, Vaarala O, Suvisaari J, Gissler M, Grainger M PLoS One. 2014; 9(8):e104845.
PMID: 25147950 PMC: 4141740. DOI: 10.1371/journal.pone.0104845.
Pisetsky D, Trace S, Brownley K, Hamer R, Zucker N, Roux-Lombard P Cytokine. 2014; 69(1):110-5.
PMID: 25022969 PMC: 4411080. DOI: 10.1016/j.cyto.2014.05.018.
NLRP3 inflammasome: a new target in major depressive disorder.
Alcocer-Gomez E, Cordero M CNS Neurosci Ther. 2014; 20(3):294-5.
PMID: 24479787 PMC: 6493047. DOI: 10.1111/cns.12230.